Merck has made headlines yet again with its $10 billion acquisition of Verona Pharma, a bold move aimed at cushioning the impending blow from the loss of exclusivity on its ...
Merck has made headlines yet again with its $10 billion acquisition of Verona Pharma, a bold move aimed at cushioning the impending blow from the loss of exclusivity on its ...